{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T16:06:11Z","timestamp":1768147571514,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Rajiv Gandhi Centre for Biotechnology"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.phrs.2016.01.012","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T21:19:04Z","timestamp":1453497544000},"page":"134-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1\/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells"],"prefix":"10.1016","volume":"105","author":[{"given":"Reshma","family":"R.S.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreelatha","family":"K.H.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Somasundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satheesh Kumar","family":"S.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revathy","family":"Nadhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh Sathish","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.01.012_bib0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2016.01.012_bib0010","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.2012.43.1882","article-title":"Germline BRCA mutations are associated with higher risk of nodal involvement distant metastasis, and poor survival outcomes in prostate cancer","volume":"31","author":"Castro","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2016.01.012_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrclinonc.2010.136","article-title":"Drug resistance in metastatic castration-resistant prostate cancer","volume":"8","author":"Seruga","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2016.01.012_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.01.012_bib0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.taap.2007.05.018","article-title":"Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II","volume":"223","author":"Kawiak","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.012_bib0030","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/1535-7163.MCT-06-0478","article-title":"Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT\/mammalian target of rapamycin pathway in breast cancer cells","volume":"5","author":"Kuo","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2016.01.012_bib0035","doi-asserted-by":"crossref","first-page":"e45023","DOI":"10.1371\/journal.pone.0045023","article-title":"The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.01.012_bib0040","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1124\/jpet.105.098863","article-title":"Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo","volume":"318","author":"Hsu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.01.012_bib0045","first-page":"785","article-title":"Anticancer mechanism of plumbagin a natural compound, on non-small cell lung cancer cells","volume":"28","author":"Gomathinayagam","year":"2008","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1158\/1541-7786.MCR-09-0257","article-title":"5-Hydroxy-2-methyl-1,4-naphthoquinone, a vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-1: potential role in chemosensitization","volume":"8","author":"Sandur","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2007.10.005","article-title":"Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species\/c-Jun N-terminal kinase pathways in human melanoma A375. S2 cells","volume":"259","author":"Wang","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2016.01.012_bib0060","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1158\/0008-5472.CAN-08-2494","article-title":"Plumbagin a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer","volume":"68","author":"Aziz","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0065","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/jcb.21966","article-title":"Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2","volume":"105","author":"Ahmad","year":"2008","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.phrs.2016.01.012_bib0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mc.20359","article-title":"Radiosensitizing effects of plumbagin in cervical cancer cells is through modulation of apoptotic pathway","volume":"47","author":"Nair","year":"2008","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.phrs.2016.01.012_bib0075","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11095-008-9533-3","article-title":"Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species","volume":"25","author":"Powolny","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pros.22585","article-title":"The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo","volume":"73","author":"Abedinpour","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.phrs.2016.01.012_bib0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/1098-2744(200008)28:4<236::AID-MC6>3.0.CO;2-H","article-title":"Altered expression of BRCA1 BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines","volume":"28","author":"Rauh-Adelmann","year":"2000","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.phrs.2016.01.012_bib0090","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdm557","article-title":"Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents","volume":"19","author":"Thasni","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phrs.2016.01.012_bib0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.stem.2011.04.007","article-title":"Eyes wide open: a critical review of sphere-formation as an assay for stem cells","volume":"8","author":"Pastrana","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2016.01.012_bib0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbamcr.2011.01.018","article-title":"Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells","volume":"1813","author":"Rybak","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2016.01.012_bib0105","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/mc.21877","article-title":"Structure activity relationship of plumbagin in BRCA1 related cancer cells","volume":"52","author":"GCS","year":"2013","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.phrs.2016.01.012_bib0110","first-page":"3197","article-title":"Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis","volume":"58","author":"Leygue","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0115","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.7314\/APJCP.2013.14.4.2325","article-title":"Plumbagin from Plumbago zeylanica L. induces apoptosis in human non-small cell lung cancer cell lines through NF- kappaB inactivation","volume":"14","author":"Xu","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.phrs.2016.01.012_bib0120","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molonc.2012.12.001","article-title":"Plumbagin a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model","volume":"7","author":"Hafeez","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.phrs.2016.01.012_bib0125","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/onc.2010.16","article-title":"Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells","volume":"29","author":"Xu","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2016.01.012_bib0130","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1158\/1078-0432.CCR-07-1078","article-title":"Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice","volume":"13","author":"Lu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0135","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI39534","article-title":"HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype","volume":"120","author":"Gilbert","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2016.01.012_bib0140","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.3748\/wjg.v18.i47.6865","article-title":"Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers","volume":"18","author":"Han","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2016.01.012_bib0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2012.11.006","article-title":"Early growth response protein 1 upregulation and nuclear translocation by 2\u2032-benzoyloxycinnamaldehyde induces prostate cancer cell death","volume":"329","author":"Kang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2016.01.012_bib0150","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1073\/pnas.83.24.9403","article-title":"The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA","volume":"83","author":"Eschenfeldt","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.01.012_bib0155","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1128\/MCB.20.15.5722-5735.2000","article-title":"Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha","volume":"20","author":"Cotter","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2016.01.012_bib0160","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1093\/nar\/26.13.3111","article-title":"Prothymosin alpha modulates the interaction of histone H1 with chromatin","volume":"26","author":"Karetsou","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0165","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/pros.20385","article-title":"Expression of prothymosin alpha is correlated with development and progression in human prostate cancers","volume":"66","author":"Suzuki","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.phrs.2016.01.012_bib0170","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/onc.2012.250","article-title":"SUMO-specific protease 1 promotes prostate cancer progression and metastasis","volume":"32","author":"Wang","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2016.01.012_bib0175","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1158\/1078-0432.CCR-09-0788","article-title":"Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward","volume":"16","author":"Menter","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0180","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1593\/neo.06280","article-title":"CCL2 is a potent regulator of prostate cancer cell migration and proliferation","volume":"8","author":"Loberg","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.phrs.2016.01.012_bib0185","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/carcin\/bgp043","article-title":"Prostate stromal cells produce CXCL-1, CXCL-2: CXCL-3 and IL-8 in response to epithelia-secreted IL-1","volume":"30","author":"Kogan-Sakin","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phrs.2016.01.012_bib0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013006905","article-title":"Chemokines and chemokine receptors as promoters of prostate cancer growth and progression","volume":"23","author":"Salazar","year":"2013","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.phrs.2016.01.012_bib0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2016.01.012_bib0200","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ceb.2009.01.021","article-title":"Mechanism of TGF-beta signaling to growth arrest apoptosis, and epithelial-mesenchymal transition","volume":"21","author":"Heldin","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.phrs.2016.01.012_bib0205","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.molcel.2008.09.002","article-title":"TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta","volume":"31","author":"Yamashita","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2016.01.012_bib0210","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1158\/1078-0432.CCR-06-2974","article-title":"Akt\/cAMP-responsive element binding protein\/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract","volume":"13","author":"Kumar","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0215","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10549-009-0612-x","article-title":"Targeting breast stem cells with the cancer preventive compounds curcumin and piperine","volume":"122","author":"Kakarala","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2016.01.012_bib0220","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/mi.8.4.9","article-title":"Targeting cancer stem cells with phytochemicals","volume":"8","author":"Kawasaki","year":"2008","journal-title":"Mol. Interv."},{"key":"10.1016\/j.phrs.2016.01.012_bib0225","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrc2196","article-title":"Vitamin D signalling pathways in cancer: potential for anticancer therapeutics","volume":"7","author":"Deeb","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2016.01.012_bib0230","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1200\/JCO.2006.06.8197","article-title":"Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators","volume":"25","author":"Beer","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2016.01.012_bib0235","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","article-title":"Prospective identification of tumorigenic prostate cancer stem cells","volume":"65","author":"Collins","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0240","doi-asserted-by":"crossref","first-page":"9703","DOI":"10.1158\/0008-5472.CAN-08-3084","article-title":"The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells","volume":"68","author":"Vander Griend","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2016.01.012_bib0245","first-page":"1395","article-title":"The antiandrogen bicalutamide activates the androgen receptor (AR) with a mutation in codon 741 through the mitogen activated protein kinase (MARK) pathway in human prostate cancer PC3 cells","volume":"24","author":"Terakawa","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phrs.2016.01.012_bib0250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-12-24","article-title":"Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden","volume":"12","author":"Abubaker","year":"2013","journal-title":"Mol. Cancer"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815300505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815300505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T20:58:00Z","timestamp":1537045080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661815300505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":50,"alternative-id":["S1043661815300505"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.01.012","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1\/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}